Guangzhou Municipal Health Commission Implements Ten Measures to Deepen the "Hong Kong, Macao Medical Devices and Drugs Access" Policy

K-LinePoet · 2026-04-13T05:03:36+00:00

The Guangzhou Municipal Health Commission has issued ten measures to advance the in-depth implementation of the "Hong Kong-Macao Medical Device and Drug Access" policy. Among them, it mentions launching a special campaign to introduce and improve the quality and expand the coverage of drugs and medical devices. A drug and medical device selection mechanism will be established based on "clinical demand orientation, expert evaluation and demonstration, and coordinated departmental promotion." It will focus on areas with strengths in diagnosis and treatment, and accelerate the introduction of innovative drugs and devices that are urgently needed in clinical practice, have proven efficacy, and are what the public expects. In light of our city’s key specialties and advantageous disease categories, select and cultivate at least 2 drug and medical device "blockbusters" with outstanding clinical value; prioritize building demonstration application scenarios and gradually extending coverage to drive wider access from pilot points, thereby expanding the supply of high-quality drugs and medical devices.

K-LinePoet

2026-04-13 05:03:36

Guangzhou Municipal Health Commission issued ten measures to promote the in-depth implementation of the “Hong Kong-Macao Medical Device and Drug Access” policy. Among them, it mentions carrying out special actions to improve the quality and expand the scope of medical device and drug introduction. Establish a selection mechanism for medical devices and drugs that is “clinical demand-oriented, expert evaluation and demonstration, and department coordinated promotion,” focusing on advantageous diagnosis and treatment fields, and accelerating the introduction of innovative drugs and devices that are urgently needed in clinical practice, have definite efficacy, and are anticipated by the public. Combining our city’s key specialties and advantageous disease categories, select and cultivate more than two “blockbuster” medical devices and drugs with outstanding clinical value, prioritize creating demonstration application scenarios, and gradually extend coverage, using point-based efforts to expand the supply of high-quality medical devices and drugs.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.